dr. brufsky on implementing pertuzumab in her2 breast cancer
Published 6 years ago • 87 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:49
dr. brufsky discusses pertuzumab in her2 breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
2:39
adam brufsky, md, phd, describes the treatment landscape of her2 metastatic breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:49
dr. rahman on pertuzumab and neratinib in her2 breast cancer
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:54
dr. tripathy discusses pertuzumab in her2 breast cancer
-
2:33
dr. brufsky discusses resistance to her2-targeted therapies
-
1:04
dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
-
1:06
dr. mark pegram on combining trastuzumab and pertuzumab
-
6:00
frontline pertuzumab for metastatic breast cancer
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
3:21
adam brufsky, md, phd, considers the investigation of poziotinib in her2 metastatic breast cancer
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc